|
Native Antigen Inc
denv1 Denv1, supplied by Native Antigen Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/Dengue+Antigens/Dengue+Virus+Serotype+1+VLP/10__1093_slash_narmme_slash_ugae025-41-6-7 Average 93 stars, based on 1 article reviews
denv1 - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Native Antigen Inc
hek293 Hek293, supplied by Native Antigen Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/Dengue+Antigens/Dengue+Virus+Serotype+4+NS1+Protein+(HEK293)/pmc10562857__mmc1-13-98-101 Average 93 stars, based on 1 article reviews
hek293 - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Native Antigen Inc
denv1 ns1 protein ![]() Denv1 Ns1 Protein, supplied by Native Antigen Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/Dengue+Antigens/Dengue+Virus+Serotype+1+NS1+Protein+(HEK293)/pmc05850648-65-1-7 Average 92 stars, based on 1 article reviews
denv1 ns1 protein - by Bioz Stars,
2026-11
92/100 stars
|
Buy from Supplier |
|
Native Antigen Inc
mouse anti denv 1 2 ns1 igg antibodies ![]() Mouse Anti Denv 1 2 Ns1 Igg Antibodies, supplied by Native Antigen Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/Dengue+Antigens/Mouse+Anti-Dengue+Virus+NS1+Serotype+1+Antibody+(OB4)/pm40710103-92-14-21 Average 94 stars, based on 1 article reviews
mouse anti denv 1 2 ns1 igg antibodies - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Native Antigen Inc
denv2 env ![]() Denv2 Env, supplied by Native Antigen Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/Dengue+Antigens/Dengue+Virus+Serotype+2+Envelope+Protein+(HEK293)/us11028133-467-20-16 Average 94 stars, based on 1 article reviews
denv2 env - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Native Antigen Inc
denv4 vlp ![]() Denv4 Vlp, supplied by Native Antigen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/Dengue+Antigens/Dengue+Virus+Serotype+4+VLP/pmc08051607-213-48-50 Average 90 stars, based on 1 article reviews
denv4 vlp - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Native Antigen Inc
cterminal poly histidine tag ![]() Cterminal Poly Histidine Tag, supplied by Native Antigen Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/Dengue+Antigens/Dengue+Virus+Serotype+2+NS1+Protein+(HEK293)/pm41402337-268-5-10 Average 94 stars, based on 1 article reviews
cterminal poly histidine tag - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Native Antigen Inc
serotype 3 ns1 ![]() Serotype 3 Ns1, supplied by Native Antigen Inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/Dengue+Antigens/Dengue+Virus+Serotype+3+NS1+Protein+(HEK293)/pmc09835594-44-18-28 Average 91 stars, based on 1 article reviews
serotype 3 ns1 - by Bioz Stars,
2026-11
91/100 stars
|
Buy from Supplier |
|
Native Antigen Inc
dengue virus serotype 2 ![]() Dengue Virus Serotype 2, supplied by Native Antigen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/Dengue+Antigens/Dengue+Virus+Serotype+2+Envelope+Protein+(Insect+Cells)/pm27982728-46-6-21 Average 90 stars, based on 1 article reviews
dengue virus serotype 2 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Native Antigen Inc
denv2 vlp 500 ![]() Denv2 Vlp 500, supplied by Native Antigen Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/Dengue+Antigens/Dengue+Virus+Serotype+2+VLP/pm41600823-52-14-6 Average 94 stars, based on 1 article reviews
denv2 vlp 500 - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Native Antigen Inc
mouse anti dengue virus pan serotype ns1 antibody ea1 ![]() Mouse Anti Dengue Virus Pan Serotype Ns1 Antibody Ea1, supplied by Native Antigen Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/Dengue+Antigens/Mouse+Anti-Dengue+Virus+Pan-Serotype+NS1+Antibody+(EA1)/10__1039_slash_D3NR01858J-51-3-46 Average 93 stars, based on 1 article reviews
mouse anti dengue virus pan serotype ns1 antibody ea1 - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Native Antigen Inc
denv4 env ![]() Denv4 Env, supplied by Native Antigen Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/Dengue+Antigens/Dengue+Virus+Serotype+4+Envelope+Protein+(HEK293)/us11028133-467-21-16 Average 92 stars, based on 1 article reviews
denv4 env - by Bioz Stars,
2026-11
92/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Article Title: Distinguishing Secondary Dengue Virus Infection From Zika Virus Infection With Previous Dengue by a Combination of 3 Simple Serological Tests
doi: 10.1093/cid/cix672
Figure Lengend Snippet: Results of Enzyme-Linked Immunosorbent Assays in Different Serum/Plasma Panels
Article Snippet: Purified
Techniques:
Journal: Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Article Title: Distinguishing Secondary Dengue Virus Infection From Zika Virus Infection With Previous Dengue by a Combination of 3 Simple Serological Tests
doi: 10.1093/cid/cix672
Figure Lengend Snippet: Sensitivity and Specificity of Enzyme-Linked Immunosorbent Assays
Article Snippet: Purified
Techniques:
Journal: Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Article Title: Distinguishing Secondary Dengue Virus Infection From Zika Virus Infection With Previous Dengue by a Combination of 3 Simple Serological Tests
doi: 10.1093/cid/cix672
Figure Lengend Snippet: Results of nonstructural protein 1 (NS1) immunoglobulin G (IgG) enzyme-linked immunosorbent assays (ELISAs) for secondary dengue virus (sDENV) and Zika virus (ZIKV) with previous (wp) DENV infection panels. DENV1-NS1 (A) and ZIKV-NS1 (B) IgG ELISAs in convalescent-phase samples from sDENV, ZIKVwpDENV (Nicaragua [Nic]), probable ZIKVwpDENV (Brazil [Bra]) and negative control (NC) panels. C, Relative optical density (rOD) ratio of ZIKV-NS1 to DENV1-NS1. The sensitivity and specificity are shown based on a cutoff rOD ratio at 0.24. DENV1-NS1 (D) and ZIKV-NS1 (E) IgG ELISAs in post–convalescent phase samples (3 months to 2 years post–symptom onset) from sDENV panels. F, Positive rates of DENV1- and ZIKV-NS1 IgG ELISAs in sDENV panels over time. Dotted lines indicate cutoff rOD values for ELISAs. Data are mean of 2 experiments (each in duplicate). Two-tailed Mann-Whitney test was used to compare the 2 groups.
Article Snippet: Purified
Techniques: Virus, Infection, Negative Control, Two Tailed Test, MANN-WHITNEY
Journal: Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Article Title: Distinguishing Secondary Dengue Virus Infection From Zika Virus Infection With Previous Dengue by a Combination of 3 Simple Serological Tests
doi: 10.1093/cid/cix672
Figure Lengend Snippet: Results of nonstructural protein 1 (NS1) immunoglobulin G (IgG) enzyme-linked immunosorbent assay (ELISAs) in sequential samples from individuals with secondary dengue virus (sDENV) and Zika virus (ZIKV) infection with previous (wp) DENV infections. A, Three cases with sDENV infection, 3–18 months post–symptom onset. B, Four blood donors with sDENV infection, 7 days to 6 months post–index day (PID). C, Five blood donors with ZIKVwpDENV infection, from index day to 3 months PID. Three cases (1, 4, and 7) seroconverted to ZIKV-NS1; 2 cases (15 and 21) had ZIKV-NS1 IgG starting from the index day. Dotted lines indicate cutoff relative optical density (rOD) values for ELISAs. Data are mean of 2 experiments (each in duplicates).
Article Snippet: Purified
Techniques: Enzyme-linked Immunosorbent Assay, Virus, Infection
Journal: Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Article Title: Distinguishing Secondary Dengue Virus Infection From Zika Virus Infection With Previous Dengue by a Combination of 3 Simple Serological Tests
doi: 10.1093/cid/cix672
Figure Lengend Snippet: Proposed algorithm of using 3 serological tests (without neutralization tests) to distinguish different Zika virus (ZIKV) and dengue virus (DENV) infections in dengue- and Zika-endemic regions in the framework of Centers for Disease Control and Prevention guidelines for laboratory diagnosis of ZIKV infection [6, 7]. Only samples tested positive or equivocal by ZIKV or DENV E protein–based immunoglobulin M (IgM) enzyme-linked immunosorbent assays (ELISAs) are included in the algorithm. The total numbers from each panel and the numbers of positive or negative based on the 3 Nonstructural Protein 1 (NS1) ELISAs are shown in parentheses. Abbreviations: IgG, immunoglobulin G; OD, optical density; pDENV, primary dengue virus infection; pZIKV, primary Zika virus infection; rOD, relative OD; sDENV, secondary dengue virus infection; ZIKVwpDENV, Zika virus infection with previous dengue virus infection.
Article Snippet: Purified
Techniques: Neutralization, Virus, Infection
Journal: Plant Biotechnology Journal
Article Title: Plant‐made dengue virus‐like particles produced by co‐expression of structural and non‐structural proteins induce a humoral immune response in mice
doi: 10.1111/pbi.13501
Figure Lengend Snippet: Analysed candidate vaccines and Coomassie‐stained SDS‐PAGE control: The respective vaccine candidates were expressed in plants, purified and analysed by SDS‐PAGE. DENV1‐VLPs were produced by co‐expressing DENV1‐SP and NSP. SDS‐PAGE shows signals for prM (18 kDa) and E (~55 kDa). Empty bluetongue core‐like particles (BTV‐CLPs) as negative control (c‐) were produced by co‐expression of BTV VP3 (103 kDa) and VP7 (39 kDa). For antigen display inside BTV‐CLPs, the E domain III (EIII) of DENV1, DENV4 and ZIKA was fused to the N terminus of BTV‐VP3. Co‐expression of BTV‐VP3 and V7 leads to assembly of CLPs and integration of the N ‐terminal fused antigens. The Coomassie‐stained SDS‐PAGE shows the size difference between c‐ VP3 and VP3 fused to EIII. The EIII soluble subunit (14 kDa) showed the expected size of 14 kDa and high purity.
Article Snippet: To detect specific antibodies, 96‐well plates (NUNC Maxisorp) were coated with 5 µg/mL of each of the following antigens diluted in carbonate–bicarbonate buffer (Thermo, Product #28382): recombinant Zika virus envelope protein (Native Antigen Company, ZIKVSU‐ENV‐100), Zika VLP (Native Antigen Company, ZIKV‐VLP‐250), DENV1 VLP (Native Antigen Company, DENV1‐VLP‐250) and
Techniques: Vaccines, Staining, SDS Page, Purification, Produced, Expressing, Negative Control
Journal: Plant Biotechnology Journal
Article Title: Plant‐made dengue virus‐like particles produced by co‐expression of structural and non‐structural proteins induce a humoral immune response in mice
doi: 10.1111/pbi.13501
Figure Lengend Snippet: Humoral response of DENV1 VLPs, EIII domains displayed in bluetongue CLPs and the DENV1‐EIII subunit. Six mice per group were immunized in a single or prime‐boost manner. Collected sera of immunized mice were tested in a dilution series against commercial DENV1, DENV4 and ZIKA VLPs, as well as recombinant ZIKA envelope protein (ZIKV‐Env). Lines show mean values with error bars denoted standard error. Only DENV1‐VLPs stimulated the production of reacting antibodies, indicating that in mice, VLPs are more efficient antigens in terms of B‐cell response than comparable amounts of the DENV1 subunit alone or the display of EIII on bluetongue CLPs.
Article Snippet: To detect specific antibodies, 96‐well plates (NUNC Maxisorp) were coated with 5 µg/mL of each of the following antigens diluted in carbonate–bicarbonate buffer (Thermo, Product #28382): recombinant Zika virus envelope protein (Native Antigen Company, ZIKVSU‐ENV‐100), Zika VLP (Native Antigen Company, ZIKV‐VLP‐250), DENV1 VLP (Native Antigen Company, DENV1‐VLP‐250) and
Techniques: Recombinant
Journal: Philosophical Transactions of the Royal Society B: Biological Sciences
Article Title: Success probability of high-affinity DNA aptamer generation by genetic alphabet expansion
doi: 10.1098/rstb.2022.0031
Figure Lengend Snippet: High-affinity Ds-DNA aptamer candidates obtained by ExSELEX. ( a ) Chemical structures of a hydrophobic unnatural base pair, Ds–Px, and the natural A–T and G–C base pairs. ( b ) Predicted secondary structures of high-affinity Ds-DNA aptamers targeting VEGF 165 , IFNγ, von Willebrand factor A1-domain (vWF), and each serotype of dengue NS1 proteins. For the anti-DEN1/2/3/4-NS1 aptamers, their core parts are shown by removing the flanking primer regions. The bases in the randomized and primer regions are shown in large and small letters, respectively. The important bases (orange circles) were estimated from the doped selections (anti-VEGF 165 and anti-IFNγ aptamers) or the obtained sequence motifs (anti-DEN1-, DEN2- and DEN4-NS1 aptamers). There is no information available for anti-vWF and DEN3-NS1, and thus the loop regions are tentatively estimated as the important bases. Green circles in the anti-vWF aptamer are the original constant complementary sequences for stem formation. In the anti-DEN2-NS1 aptamer, the four G tracts that form a G-quadruplex structure are shown by red Gs. The dashed lines in the anti-DEN4-NS1 aptamer represent a stem region found in the internal loop region. ( c ) Estimation of the occurrence of the aptamer candidates in the initial library based on ExSELEX data. (Online version in colour.)
Article Snippet: Recombinant proteins, human vWF A1-domain (vWF: amino acids 1238–1481), human IFNγ, and dengue virus serotype-1 NS1 (DEN1-NS1) and
Techniques: Sequencing
Journal: Philosophical Transactions of the Royal Society B: Biological Sciences
Article Title: Success probability of high-affinity DNA aptamer generation by genetic alphabet expansion
doi: 10.1098/rstb.2022.0031
Figure Lengend Snippet: Binding analysis of Ds-DNA aptamer variants with point transition mutations. ( a ) EMSA for the anti-vWF Ds-DNA aptamer variants. ( b – e ) Relative binding efficiencies (%) of each variant of anti-IFNγ Ds-DNA aptamer ( b ), anti-vWF Ds-DNA aptamer ( c ), anti-DEN1-NS1 Ds-DNA aptamer ( d ), and anti-DEN3-NS1 Ds-DNA aptamer ( e ), determined with normalization of the complex formation efficiency of each original Ds-DNA aptamer (electronic supplementary material, figure S3) from EMSA (electronic supplementary material, figures S5–S7). The Ds positions are shown by red bars. The positions that exhibited less than 65% of the relative binding efficiencies (average) were assigned as the essential base positions and are shown by orange bars. ( f ) Re-estimation of the occurrence of the aptamer candidates in the initial library used, according to the important/essential bases identified by EMSA. (Online version in colour.)
Article Snippet: Recombinant proteins, human vWF A1-domain (vWF: amino acids 1238–1481), human IFNγ, and dengue virus serotype-1 NS1 (DEN1-NS1) and
Techniques: Binding Assay, Variant Assay